Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
Li L, Pilo GM, Li X, Cigliano A, Latte G, Che L, Joseph C, Mela M, Wang C, Jiang L, Ribback S, Simile MM, Pascale RM, Dombrowski F, Evert M, Semenkovich CF, Chen X, Calvisi DF.
Li L, et al. Among authors: che l.
J Hepatol. 2016 Feb;64(2):333-341. doi: 10.1016/j.jhep.2015.10.004. Epub 2015 Oct 22.
J Hepatol. 2016.
PMID: 26476289
Free PMC article.